Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3KZ4Y
|
|||
| Drug Name |
OG2023SC
|
|||
| Synonyms |
NNC0113-2023; NN9023
Click to Show/Hide
|
|||
| Indication | Type 2 diabetes [ICD-11: 5A11; ICD-10: E08-E13] | Phase 1 | [1] | |
| Company |
Novo Nordisk
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03617081) First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.